Tg Therapeutics (TGTX) Interest Coverage Ratio (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Interest Coverage Ratio of 4.54 for Q1 2026, up 255.71% year-over-year from 1.28 in Q1 2025, and down 63.55% quarter-over-quarter from 12.45 in Q4 2025.
Tg Therapeutics (TGTX) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Tg Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 4.54 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 255.71% year-over-year to 4.54; the TTM figure through Mar 2026 stood at 5.93 (up 58.17% YoY), while the FY2025 annual figure was 1.28, up 215.48% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 4.54, down from 12.45 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 41.16 in Q4 2022, with the low at 13.01 in Q1 2023.
- The 5-year median for Interest Coverage Ratio is 0.94 (2024), against an average of 3.79.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio tumbled 421.96% in 2023, then surged 872.79% in 2024.
- Tg Therapeutics' Interest Coverage Ratio stood at 41.16 in 2022, then tumbled by 106.27% to 2.58 in 2023, then soared by 872.79% to 19.93 in 2024, then tumbled by 37.51% to 12.45 in 2025, then plunged by 63.55% to 4.54 in 2026.
- Business Quant data shows TGTX's Interest Coverage Ratio at 4.54 in Q1 2026, 12.45 in Q4 2025, and 2.66 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 1.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 |
| Mar 31, 2026 | 4.54 |
| Dec 31, 2025 | 12.45 |
| Sep 30, 2025 | 2.66 |
| Jun 30, 2025 | 5.19 |
| Mar 31, 2025 | 1.28 |
| Dec 31, 2024 | 19.93 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -2.58 |
| Sep 30, 2023 | 19.79 |
| Jun 30, 2023 | -11.76 |
| Mar 31, 2023 | -13.01 |
| Dec 31, 2022 | 41.16 |
| Sep 30, 2022 | -5.83 |
| Jun 30, 2022 | -2.25 |
| Mar 31, 2022 | -8.09 |
| Dec 31, 2021 | -31.61 |
| Sep 30, 2021 | -4.72 |